A detailed history of Gamma Investing LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gamma Investing LLC holds 7,967 shares of NVO stock, worth $857,488. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,967
Previous 7,150 11.43%
Holding current value
$857,488
Previous $1.02 Billion 7.05%
% of portfolio
0.09%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$119.07 - $145.42 $97,280 - $118,808
817 Added 11.43%
7,967 $949 Million
Q2 2024

Jul 02, 2024

BUY
$122.71 - $146.91 $99,272 - $118,850
809 Added 12.76%
7,150 $1.02 Billion
Q1 2024

Apr 05, 2024

BUY
$102.11 - $135.92 $87,406 - $116,347
856 Added 15.61%
6,341 $814 Million
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $481,473 - $578,393
5,485 New
5,485 $629 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.